NADPH oxidases in bone homeostasis and osteoporosis
- PMID: 30189265
- DOI: 10.1016/j.freeradbiomed.2018.08.036
NADPH oxidases in bone homeostasis and osteoporosis
Abstract
Bone is a tissue with constant remodeling, where osteoblasts form and osteoclasts degrade bone. Both cell types are highly specialized in their function and both form from precursors and have to be replaced on a regular basis. This replacement represents one control level of bone homeostasis. The second important level would be the control of the function of osteoblasts and osteoclasts in order to keep the balance of bone -formation and -degradation. Both differentiation and control of cellular function are potentially redox sensitive processes. In fact, reactive oxygen species (ROS) are utilized by a wide range of cells for differentiation and control of cellular signaling and function. A major source of ROS is the family of NADPH oxidases. The sole function of those enzymes is the formation of ROS in a controlled and targeted manner. Importantly the members of the NADPH oxidase family differ in their localization and in the type and amount of ROS produced. Accordingly the impact of the members of the NADPH oxidase family on differentiation and function differs between cell types. This review will highlight the function of different NADPH oxidases in differentiation and function of bone cells and thereby will discuss the role of NADPH oxidases in bone homeostasis and osteoporosis.
Keywords: Bone; NADPH oxidase; Osteoblast; Osteoclast; Reactive oxygen species.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
NADPH oxidases in bone homeostasis and osteoporosis.Cell Mol Life Sci. 2015 Jan;72(1):25-38. doi: 10.1007/s00018-014-1712-2. Epub 2014 Aug 29. Cell Mol Life Sci. 2015. PMID: 25167924 Free PMC article. Review.
-
NADPH oxidases in the differentiation of endothelial cells.Cardiovasc Res. 2020 Feb 1;116(2):262-268. doi: 10.1093/cvr/cvz213. Cardiovasc Res. 2020. PMID: 31393561 Review.
-
NADPH Oxidases and Their Roles in Skin Homeostasis and Carcinogenesis.Antioxid Redox Signal. 2018 May 1;28(13):1238-1261. doi: 10.1089/ars.2017.7282. Epub 2017 Nov 17. Antioxid Redox Signal. 2018. PMID: 28990413 Review.
-
NADPH oxidase-derived reactive oxygen species: Dosis facit venenum.Exp Physiol. 2019 Apr;104(4):447-452. doi: 10.1113/EP087125. Epub 2019 Mar 7. Exp Physiol. 2019. PMID: 30737851 Free PMC article. Review.
-
NADPH oxidases in bone and cartilage homeostasis and disease: A promising therapeutic target.J Orthop Res. 2020 Oct;38(10):2104-2112. doi: 10.1002/jor.24693. Epub 2020 Apr 26. J Orthop Res. 2020. PMID: 32285964 Review.
Cited by
-
Nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency causes age-dependent progression of female osteoporosis.BMC Musculoskelet Disord. 2022 Nov 25;23(1):1015. doi: 10.1186/s12891-022-05942-1. BMC Musculoskelet Disord. 2022. PMID: 36434613 Free PMC article.
-
Advances in the study of traditional Chinese medicine affecting bone metabolism through modulation of oxidative stress.Front Pharmacol. 2023 Nov 1;14:1235854. doi: 10.3389/fphar.2023.1235854. eCollection 2023. Front Pharmacol. 2023. PMID: 38027015 Free PMC article. Review.
-
Bone Regeneration and Oxidative Stress: An Updated Overview.Antioxidants (Basel). 2022 Feb 6;11(2):318. doi: 10.3390/antiox11020318. Antioxidants (Basel). 2022. PMID: 35204201 Free PMC article. Review.
-
NADPH Oxidase Isoforms Are Involved in Glucocorticoid-Induced Preosteoblast Apoptosis.Oxid Med Cell Longev. 2019 Mar 27;2019:9192413. doi: 10.1155/2019/9192413. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31049140 Free PMC article.
-
Therapeutic prospects and potential mechanisms of Prdx6: as a novel target in musculoskeletal disorders.Front Physiol. 2025 Apr 17;16:1524100. doi: 10.3389/fphys.2025.1524100. eCollection 2025. Front Physiol. 2025. PMID: 40313876 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical